Affiliation:
1. University of Montana Division of Biological Sciences
2. Silverlake Research Corporation
3. Arizona State University School of Life Sciences
4. University of California San Diego
5. University of Montana
6. University of Montana Missoula: University of Montana
Abstract
Abstract
BACKGROUND
Many tumors contain hypoxic microenvironments caused by inefficient tumor vascularization. Hypoxic tumors have been shown to resist conventional cancer therapies. Hypoxic cancer cells rely on glucose to meet their energetic and anabolic needs to fuel uncontrolled proliferation and metastasis. This glucose dependency is linked to a metabolic shift in response to hypoxic conditions.
METHODS
To leverage the glucose dependency of hypoxic tumor cells, we assessed the effects of a controlled reduction in systemic glucose by combining dietary carbohydrate restriction, using a ketogenic diet, with gluconeogenesis inhibition, using metformin, on two mouse models of triple-negative breast cancer (TNBC).
RESULTS
We confirmed that MET − 1 breast cancer cells require abnormally high glucose concentrations to survive in a hypoxic environment in vitro. Then, we showed that, compared to a ketogenic diet or metformin alone, animals treated with the combination regimen showed significantly lower tumor burden, higher tumor latency and slower tumor growth. As a result, lowering systemic glucose by this combined dietary and pharmacologic approach improved overall survival in our mouse model by 31 days, which is approximately equivalent to 3 human years.
CONCLUSION
This is the first preclinical study to demonstrate that reducing systemic glucose by combining a ketogenic diet and metformin significantly inhibits tumor proliferation and increases overall survival. Our findings suggest a possible treatment for a broad range of hypoxic and glycolytic tumor types, one that can also augment existing treatment options to improve patient outcomes.
Publisher
Research Square Platform LLC
Reference71 articles.
1. Defining normoxia, physoxia and hypoxia in tumours—implications for treatment response;McKeown SR;BJR,2014
2. The hypoxic tumor microenvironment: A driving force for breast cancer progression;Semenza GL;Biochim et Biophys Acta - Mol Cell Res,2016
3. Tumor Hypoxia in Cancer Therapy;Brown JM;Methods Enzymol,2007
4. Hypoxic control of metastasis;Rankin EB;Science,2016
5. Li XF, Ma Y, Jiang H. Understanding hypoxia microenvironment of micrometastases. Journal of Solid Tumors [Internet]. 2012 [cited 2018 Oct 21];2(2). Available from: http://www.sciedu.ca/journal/index.php/jst/article/view/740.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献